Structures by: Wardell J. L.
Total: 659
N-(4-Methylphenyl)-2-chloronicotinamide
C13H11ClN2O
Acta Crystallographica Section B (2006) 62, 4 651-665
a=9.6824(6)Å b=11.3082(7)Å c=11.5139(7)Å
α=77.453(2)° β=73.445(2)° γ=87.978(2)°
N-(4-Fluorophenyl)-2-chloronicotinamide monohydrate
C12H8ClFN2O,H2O
Acta Crystallographica Section B (2006) 62, 4 651-665
a=6.8033(4)Å b=8.1303(3)Å c=11.5356(6)Å
α=84.032(3)° β=84.297(2)° γ=69.569(3)°
N-(4-Chlorophenyl-2-chloronicotinamide
C12H8Cl2N2O
Acta Crystallographica Section B (2006) 62, 4 651-665
a=5.0855(8)Å b=28.982(8)Å c=15.607(4)Å
α=90.00° β=90.37(2)° γ=90.00°
N-(4-Iodophenyl)-2-chloronicotinamide
C12H8ClIN2O
Acta Crystallographica Section B (2006) 62, 4 651-665
a=10.6597(2)Å b=25.9833(3)Å c=9.2044(6)Å
α=90.00° β=90.00° γ=90.00°
N-(4-bromophenyl)-2-chloronicotinamide
C12H8BrClN2O
Acta Crystallographica Section B (2006) 62, 4 651-665
a=4.8810(2)Å b=13.3448(2)Å c=18.3974(3)Å
α=90.00° β=90.00° γ=90.00°
N-(4-Methoxyphenyl)-2-chloronicotinamide
C13H11ClN2O2
Acta Crystallographica Section B (2006) 62, 4 651-665
a=4.8536(2)Å b=11.8437(4)Å c=21.0612(7)Å
α=90.00° β=90.00° γ=90.00°
N-(4-Cyanophenyl)-2-chloronicotinamide
C13H8ClN3O
Acta Crystallographica Section B (2006) 62, 4 651-665
a=7.2885(3)Å b=7.7607(3)Å c=20.8849(9)Å
α=96.456(2)° β=92.913(2)° γ=91.810(2)°
N-(2-iodophenyl)-3-nitrobenzamide
C13H9IN2O3
Acta Crystallographica, Section B (2006) 62, 2 931-943
a=13.1804(3)Å b=7.5099(2)Å c=13.8849(3)Å
α=90.00° β=111.1634(12)° γ=90.00°
N-(2-iodophenyl)-4-nitrobenzamide
C13H9IN2O3
Acta Crystallographica, Section B (2006) 62, 2 931-943
a=10.0528(3)Å b=4.8703(10)Å c=13.5719(3)Å
α=90.00° β=109.9452(17)° γ=90.00°
N-(3-iodophenyl)-3-nitrobenzamide
C13H9IN2O3
Acta Crystallographica, Section B (2006) 62, 2 931-943
a=13.8494(4)Å b=10.0495(3)Å c=9.4203(3)Å
α=90.00° β=105.2353(16)° γ=90.00°
N-(3-iodophenyl)-2-nitrobenzamide
C13H9IN2O3
Acta Crystallographica, Section B (2006) 62, 2 931-943
a=11.0552(3)Å b=8.9521(2)Å c=12.8921(3)Å
α=90.00° β=96.3899(10)° γ=90.00°
N-(3-iodophenyl)-4-nitrobenzamide
C13H9IN2O3
Acta Crystallographica, Section B (2006) 62, 2 931-943
a=7.4798(2)Å b=14.0889(7)Å c=11.8138(6)Å
α=90.00° β=93.259(3)° γ=90.00°
N-(4-iodophenyl)-4-nitrobenzamide
C13H9IN2O3
Acta Crystallographica, Section B (2006) 62, 2 931-943
a=5.1047(3)Å b=15.3015(9)Å c=16.4806(9)Å
α=95.356(2)° β=95.498(2)° γ=91.150(2)°
(E,E)-1,4-Bis(2-nitrophenyl)-2,3-diaza-1,3-butadiene
C14H10N4O4
Acta Crystallographica Section B (2006) 62, 4 666-675
a=7.7809(2)Å b=14.7825(6)Å c=6.2196(2)Å
α=90.00° β=113.106(2)° γ=90.00°
(E,E)-1,4-Bis(2-nitrophenyl)-2,3-diaza-1,3-butadiene
C14H10N4O4
Acta Crystallographica Section B (2006) 62, 4 666-675
a=9.1379(4)Å b=6.1776(3)Å c=11.7682(4)Å
α=90.00° β=93.853(3)° γ=90.00°
(E,E)-1,4-Bis(2-nitrophenyl)-2,3-diaza-1,3-butadiene
C14H10N4O4
Acta Crystallographica Section B (2006) 62, 4 666-675
a=7.0128(4)Å b=7.6318(5)Å c=12.8037(5)Å
α=90.00° β=105.825(3)° γ=90.00°
N-isonicotinoyl benzaldehydehydrazone
C13H11N3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.1927(2)Å b=21.2168(7)Å c=28.6771(10)Å
α=90.00° β=90.00° γ=90.00°
N-isonicotinoyl 2-fluorobenzaldehydehydrazone
C13H10FN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.4815(2)Å b=11.1344(2)Å c=14.5365(3)Å
α=90.663(2)° β=104.903(3)° γ=109.268(2)°
N-isonicotinoyl 4-fluorobenzaldehydehydrazone monohydrate
C13H10FN3O,H2O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=6.4189(3)Å b=6.8520(3)Å c=27.3451(12)Å
α=90.00° β=90.00° γ=90.00°
N-isonicotinoyl 2-chlorobenzaldehydehydrazone
C13H10ClN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.9977(2)Å b=6.7184(2)Å c=22.5514(6)Å
α=90.00° β=98.609(3)° γ=90.00°
N-isonicotinoyl 3-chlorobenzaldehydehydrazone
C13H10ClN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.4524(3)Å b=11.2367(4)Å c=14.3949(3)Å
α=90.00° β=102.701(2)° γ=90.00°
N-isonicotinoyl 3-bromobenzaldehydehydrazone
C13H10BrN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.4578(2)Å b=11.3264(3)Å c=14.3558(3)Å
α=90.00° β=101.119(2)° γ=90.00°
N-isonicotinoyl 2-bromobenzaldehydehydrazone
C13H10BrN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=8.0268(2)Å b=6.7134(3)Å c=22.5024(10)Å
α=90.00° β=99.297(3)° γ=90.00°
N-isonicotinoyl 3-methoxybenzaldehydehydrazone
C14H13N3O2
Acta Crystallographica Section B (2007) 63, 6 879-895
a=8.2938(4)Å b=11.0771(6)Å c=13.846(5)Å
α=90.00° β=103.478(3)° γ=90.00°
N-isonicotinoyl 4-bromobenzaldehydehydrazone
C13H10BrN3O,H2O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=14.2570(3)Å b=14.6299(4)Å c=14.1669(4)Å
α=90.00° β=119.152(2)° γ=90.00°
N-isonicotinoyl 2-methoxybenzaldehydehydrazone
C14H13N3O2
Acta Crystallographica Section B (2007) 63, 6 879-895
a=9.8899(3)Å b=15.8189(4)Å c=17.0380(5)Å
α=90.00° β=97.236(2)° γ=90.00°
N-isonicotinoyl 4-methoxybenzaldehydehydrazone
C14H13N3O2,H2O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=7.2702(2)Å b=12.3085(5)Å c=14.7299(6)Å
α=90.00° β=97.370(3)° γ=90.00°
N-isonicotinoyl 2-ethoxybenzaldehydehydrazone
C15H15N3O2
Acta Crystallographica Section B (2007) 63, 6 879-895
a=8.3787(3)Å b=18.2450(7)Å c=17.8701(7)Å
α=90.00° β=90.975(2)° γ=90.00°
N-isonicotinoyl 3-ethoxybenzaldehydehydrazone
C15H15N3O2
Acta Crystallographica Section B (2007) 63, 6 879-895
a=24.2060(17)Å b=5.5637(4)Å c=9.9571(4)Å
α=90.00° β=94.965(4)° γ=90.00°
N-isonicotinoyl 3-fluorobenzaldehydehydrazone
C13H10FN3O
Acta Crystallographica Section B (2007) 63, 6 879-895
a=13.1910(4)Å b=18.8057(6)Å c=18.2843(4)Å
α=90.00° β=90.00° γ=90.00°
N-phenylpyrazinecarboxamide
C11H9N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.9716(3)Å b=7.5270(4)Å c=11.0318(6)Å
α=83.295(3)° β=85.377(4)° γ=69.009(3)°
N-(2-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=15.5361(9)Å b=7.0360(3)Å c=18.9863(9)Å
α=90.00° β=91.307(2)° γ=90.00°
N-(3-methylphenyl)pyrazinecarboxamide
C12H11N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=10.2736(4)Å b=10.8639(4)Å c=18.5040(5)Å
α=90.00° β=90.1970(19)° γ=90.00°
N-(2-trifluoromethylphenyl)pyrazinecarboxamide
C12H8F3N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=7.6748(3)Å b=7.8967(3)Å c=9.8421(5)Å
α=96.682(2)° β=103.357(3)° γ=101.659(2)°
N-(4-trifluoromethylphenyl)pyrazinecarboxamide
C12H8F3N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.8885(6)Å b=7.5257(9)Å c=13.2762(16)Å
α=78.349(7)° β=86.460(8)° γ=70.146(8)°
N-(4-fluorophenyl)pyrazinecarboxamide, P2~1~/c polymorph
C11H8FN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=11.718(2)Å b=5.9726(10)Å c=13.474(2)Å
α=90.00° β=91.446(9)° γ=90.00°
N-(3-chlorophenyl)pyrazinecarboxamide
C11H8ClN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=9.9121(3)Å b=10.9457(3)Å c=18.6827(4)Å
α=90.00° β=92.026(2)° γ=90.00°
N-(4-chlorophenyl)pyrazinecarboxamide
C11H8ClN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.8636(3)Å b=7.2433(5)Å c=13.1459(9)Å
α=100.854(3)° β=97.750(4)° γ=110.783(4)°
N-(4-fluorophenyl)pyrazinecarboxamide, Pc polymorph
C11H8FN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.9666(3)Å b=24.2205(15)Å c=13.0262(7)Å
α=90.00° β=91.720(3)° γ=90.00°
N-(2-methoxyphenyl)pyrazinecarboxamide
C12H11N3O2
Acta Crystallographica Section B (2008) 64, 1 84-100
a=14.1667(4)Å b=20.7513(6)Å c=7.4516(3)Å
α=90.00° β=90.00° γ=90.00°
N-(3-methoxyphenyl)pyrazinecarboxamide
C12H11N3O2,H2O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=6.9386(2)Å b=8.5820(3)Å c=19.0670(6)Å
α=90.00° β=99.394(2)° γ=90.00°
N-(2-nitrophenyl)pyrazinecarboxamide?
C11H8N4O3
Acta Crystallographica Section B (2008) 64, 1 84-100
a=3.6598(2)Å b=21.7123(17)Å c=13.1158(10)Å
α=90.00° β=91.281(5)° γ=90.00°
N-(2,6-difluorophenyl)pyrazinecarboxamide
C11H7F2N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=9.8054(4)Å b=10.9355(5)Å c=19.4805(9)Å
α=90.00° β=103.474(2)° γ=90.00°
N-(2,6-dimethylphenyl)pyrazinecarboxamide
C13H13N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=7.3977(4)Å b=10.7671(5)Å c=15.2457(4)Å
α=90.00° β=101.665(3)° γ=90.00°
N-(2-chloro-4-fluorophenyl)pyrazinecarboxamide
C11H7ClFN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=18.733(4)Å b=3.8502(8)Å c=14.839(3)Å
α=90.00° β=99.472(3)° γ=90.00°
N-(4-chloro-2-fluorophenyl)pyrazinecarboxamide
C11H7ClFN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=6.8885(2)Å b=10.5369(5)Å c=14.6683(7)Å
α=90.00° β=99.008(3)° γ=90.00°
1-(2-chloronicotinoyl)-2-(2-nitrophenyl)hydrazine, Cc polymorph
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=4.8443(2)Å b=22.7344(16)Å c=11.4216(8)Å
α=90.00° β=97.636(4)° γ=90.00°
1-(2-chloronicotinoyl)-2-(2-nitrophenyl)hydrazine, Pbcn polymorph
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=22.2727(3)Å b=8.2207(4)Å c=13.5916(7)Å
α=90.00° β=90.00° γ=90.00°
1-(2-chloronicotinoyl)-2-(2-nitrophenyl)hydrazine, P2~1~ polymorph
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=6.1515(9)Å b=4.7875(5)Å c=20.748(3)Å
α=90.000° β=97.540(7)° γ=90.000°
1-(2-chloronicotinoyl)-2-(3-nitrophenyl)hydrazine
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=9.0691(3)Å b=19.6472(5)Å c=7.4302(3)Å
α=90.00° β=110.424(2)° γ=90.00°
1-(2-chloronicotinoyl)-2-(4-nitrophenyl)hydrazine
C12H9ClN4O3
Acta Crystallographica Section B (2007) 63, 1 101-110
a=4.58110(10)Å b=24.8913(13)Å c=11.2782(6)Å
α=90.00° β=94.095(3)° γ=90.00°
2-Iodo-5-nitro-aniline
C6H5IN2O2
Acta Crystallographica Section B (2002) 58, 4 701-709
a=6.4236(15)Å b=7.4979(18)Å c=8.293(2)Å
α=71.422(4)° β=85.285(4)° γ=86.125(4)°
4-Iodo-2-nitroaniline
C6H5IN2O2
Acta Crystallographica Section B (2002) 58, 4 701-709
a=26.5541(9)Å b=7.0445(2)Å c=16.4416(5)Å
α=90.00° β=101.1548(16)° γ=90.00°
1-(2-Nitrophenylthio)-2,5-pyrrolidinedione
C10H8N2O4S
Acta Crystallographica Section B (2000) 56, 1 58-67
a=7.918(5)Å b=13.132(5)Å c=10.983(5)Å
α=90.00° β=110.7(3)° γ=90.00°
S-(2-Nitrophenyl)benzenecarbothiolate
C13H9NO3S
Acta Crystallographica Section B (2000) 56, 1 58-67
a=7.51(5)Å b=21.16(5)Å c=7.66(5)Å
α=90.00° β=92.043(10)° γ=90.00°
(E)-1-(4-methyl-2-nitrobenzenethiolato)-2-phenylethene
C15H13NO2S
Acta Crystallographica Section B (2000) 56, 1 58-67
a=21.595(3)Å b=14.518(2)Å c=7.9530(7)Å
α=90.00° β=90.00° γ=90.00°
2-Iodo-N-(4-nitrobenzyl)aniline
C13H11IN2O2
Acta Crystallographica Section B (2004) 60, 4 472-480
a=16.1564(6)Å b=9.3589(3)Å c=8.3326(3)Å
α=90.00° β=96.3330(10)° γ=90.00°
3-Iodo-N-(4-nitrobenzyl))aniline
C13H11IN2O2
Acta Crystallographica Section B (2004) 60, 4 472-480
a=7.0966(2)Å b=12.5908(4)Å c=13.8360(6)Å
α=90.00° β=90.00° γ=90.00°
4-Iodo-N-(3-nitrobenzyl))aniline
C13H11IN2O2
Acta Crystallographica Section B (2004) 60, 4 472-480
a=21.2778(15)Å b=8.1809(5)Å c=7.2793(4)Å
α=90.00° β=94.316(2)° γ=90.00°
2,2,3,3',4,4'-Hexaacetato-6,6'-bis-O-(4-toluenesulfonyl)-α,α'-trehalose
C38H46O21S2
Acta Crystallographica Section B (2004) 60, 4 461-471
a=18.1484(9)Å b=21.1046(9)Å c=23.4224(14)Å
α=90.00° β=90.00° γ=90.00°
2-Iodo-N-(2-nitrobenzyl))aniline
C13H11IN2O2
Acta Crystallographica Section B (2004) 60, 4 472-480
a=8.16850(10)Å b=10.8834(2)Å c=15.4372(2)Å
α=76.9219(9)° β=80.0727(7)° γ=74.2167(7)°
2,2,3,3',4,4'-Hexaacetato-6,6'-bis-O-methylsulfonyl-α,α'-trehalose
C26H38O21S2
Acta Crystallographica Section B (2004) 60, 4 461-471
a=21.3279(8)Å b=8.9299(4)Å c=8.8382(4)Å
α=90.00° β=99.4537(17)° γ=90.00°
2,2,3,3'-Tetraacetato-6,6'-bis(N-acetylamino)-α,α'-trehalose dihydrate
C24H36N2O15,2(H2O)
Acta Crystallographica Section B (2004) 60, 4 461-471
a=8.8385(2)Å b=21.8363(8)Å c=8.0831(2)Å
α=90.00° β=90.00° γ=90.00°
2,2,3,3',4,4'-Hexaacetato-6,6'-diazido-α,α'-trehalose ethanol solvate
C24H32N6O15,0.35(C2H6O)
Acta Crystallographica Section B (2004) 60, 4 461-471
a=12.2281(4)Å b=15.5803(6)Å c=18.1066(8)Å
α=90.00° β=90.00° γ=90.00°
6-(4-Ethoxybenzylidene)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one
C20H20O2
Acta Crystallographica Section E (2019) 75, 11 1741-1747
a=12.6208(2)Å b=14.99690(17)Å c=8.39151(12)Å
α=90° β=108.6814(17)° γ=90°
6-(4-Methoxybenzylidene)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one
C19H18O2
Acta Crystallographica Section E (2019) 75, 11 1741-1747
a=10.9171(3)Å b=9.1262(2)Å c=15.2539(3)Å
α=90° β=108.618(3)° γ=90°
2-(4-Chlorobenzylidene)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one
C18H15ClO
Acta Crystallographica Section E (2019) 75, 11 1741-1747
a=10.6273(5)Å b=11.6191(4)Å c=12.1114(5)Å
α=90° β=108.777(4)° γ=90°
6-(4-Cyanobenzylidene)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one
C19H15NO
Acta Crystallographica Section E (2019) 75, 11 1741-1747
a=12.4725(4)Å b=7.1718(2)Å c=15.9983(5)Å
α=90° β=106.120(3)° γ=90°
2-(4-Benzylbenzylidene)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-5-one
C25H22O2
Acta Crystallographica Section E (2019) 75, 11 1741-1747
a=9.2870(2)Å b=9.8727(2)Å c=12.2944(3)Å
α=67.098(3)° β=81.472(2)° γ=61.989(3)°
3-[(4-Nitrobenzylidene)amino]-2(<i>R,S</i>)-(4-nitrophenyl)-5(<i>S</i>)-(propan-2-yl)imidazolidin-4-one
C19H19N5O5
Acta Crystallographica Section E (2019) 75, 11 1774-1782
a=6.93460(10)Å b=8.4380(2)Å c=16.6963(5)Å
α=79.826(2)° β=89.848(2)° γ=80.488(2)°
2-{[2,8-Bis(trifluoromethyl)quinolin-4-yl](hydroxy)methyl}piperidin-1-ium chlorodifluoroacetate
C17H17F6N2O,C2ClF2O2
Acta Crystallographica Section E (2018) 74, 7 895-900
a=14.4535(4)Å b=6.3387(2)Å c=23.9040(8)Å
α=90° β=104.214(2)° γ=90°
2-{[2,8-Bis(trifluoromethyl)quinolin-4-yl](hydroxy)methyl}piperidin-1-ium trichloroacetate
C17H17F6N2O,C2Cl3O2
Acta Crystallographica Section E (2018) 74, 12 1851-1856
a=6.8087(2)Å b=11.8568(5)Å c=15.2562(6)Å
α=67.473(2)° β=81.663(2)° γ=89.824(3)°
2-Amino-4-nitrobenzoate (2-hydroxyethyl)dimethylazanium
C4H12NO,C7H5N2O4
Acta Crystallographica Section E (2018) 74, 12 1735-1740
a=6.6816(2)Å b=22.8286(8)Å c=8.6570(3)Å
α=90° β=104.551(2)° γ=90°
2-Amino-4-nitrobenzoate 1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium
C4H12NO3,C7H5N2O4
Acta Crystallographica Section E (2018) 74, 12 1735-1740
a=13.6269(6)Å b=9.4976(3)Å c=10.2042(4)Å
α=90° β=90.355(2)° γ=90°
2-Amino-4-nitrobenzoate <i>tert</i>-butyl(2-hydroxyethyl)azanium
C6H16NO,C7H5N2O4
Acta Crystallographica Section E (2018) 74, 12 1735-1740
a=21.1138(5)Å b=12.3635(5)Å c=13.1909(4)Å
α=90° β=120.627(2)° γ=90°
Dimethylazanium 2-amino-4-nitrobenzoate
C2H8N,C7H5N2O4
Acta Crystallographica Section E (2016) 72, 12 1691-1699
a=11.2593(5)Å b=7.5563(2)Å c=13.0437(6)Å
α=90° β=96.716(2)° γ=90°
Dibutylazanium 2-amino-4-nitrobenzoate
C8H20N,C7H5N2O4
Acta Crystallographica Section E (2016) 72, 12 1691-1699
a=11.1615(3)Å b=12.5172(4)Å c=13.2399(4)Å
α=82.4050(10)° β=78.107(2)° γ=70.915(2)°
2-{[2,8-Bis(trifluoromethyl)quinolin-4-yl](hydroxy)methyl}piperidin-1-ium 2-hydroxy-2-phenylacetate hemihydrate
2(C17H17F6N2O),2(C8H7O3),H2O
Acta Crystallographica Section E (2016) 72, 11 1618-1627
a=9.5317(2)Å b=15.8217(5)Å c=16.2980(5)Å
α=85.926(2)° β=77.418(2)° γ=83.003(2)°
Hydrazinium 2-amino-4-nitrobenzoate dihydrate
H5N2,C7H5N2O4,2(H2O)
Acta Crystallographica Section E (2017) 73, 4 579-585
a=6.9695(2)Å b=8.0960(3)Å c=10.5316(3)Å
α=76.468(2)° β=73.251(2)° γ=75.390(2)°
2-[2-(3-Nitrobenzenesulfonyl)hydrazinyl]-1,3-benzothiazole
C13H10N4O4S2
Acta Crystallographica Section E (2018) 74, 5 673-677
a=6.83537(15)Å b=13.5788(3)Å c=15.6907(4)Å
α=99.382(2)° β=98.2324(19)° γ=91.9841(19)°
2-[2-(Propan-2-ylidene)hydrazinyl]-1,3-benzothiazol-3-ium 3-nitrobenzenesulfonate
C10H12N3S,C6H4NO5S
Acta Crystallographica Section E (2018) 74, 5 673-677
a=7.5308(4)Å b=10.9167(7)Å c=12.4438(8)Å
α=66.058(6)° β=79.034(5)° γ=72.156(5)°
2-[2-(3-Nitrobenzenesulfonyl)hydrazinyl]-1,3-benzothiazol-3-ium; 3-nitrobenzenesulfonate
C13H11N4O4S2,C6H4NO5S
Acta Crystallographica Section E (2018) 74, 5 673-677
a=10.0399(5)Å b=10.7585(4)Å c=11.3372(6)Å
α=85.607(4)° β=71.369(5)° γ=77.115(4)°
2-Methoxy-benzaldehyde oxime
C8H9NO2
Acta Crystallographica Section E (2018) 74, 11 1553-1560
a=11.1719(2)Å b=16.4260(3)Å c=4.02490(10)Å
α=90° β=90° γ=90°
2,3-Dimethoxy-benzaldehyde oxime
C9H11NO3
Acta Crystallographica Section E (2018) 74, 11 1553-1560
a=4.6775(2)Å b=13.0996(5)Å c=14.1984(5)Å
α=90° β=90° γ=90°
2,4-Dimethoxybenzaldehyde oxime
C9H11NO3
Acta Crystallographica Section E (2018) 74, 11 1553-1560
a=4.9441(2)Å b=8.2188(4)Å c=12.1308(3)Å
α=108.849(3)° β=92.288(3)° γ=106.273(4)°
2,5-Dimethoxybenzaldehyde oxime
C9H11NO3
Acta Crystallographica Section E (2018) 74, 11 1553-1560
a=7.64800(10)Å b=21.3380(4)Å c=10.9421(2)Å
α=90° β=90.555(2)° γ=90°
(<i>E</i>)-<i>N</i>'-Benzylidene-2-oxo-2<i>H</i>-chromene-3-carbohydrazide
C17H12N2O3
Acta Crystallographica Section E (2019) 75, 10 1403-1410
a=5.67150(10)Å b=7.41640(10)Å c=15.9819(3)Å
α=88.3690(10)° β=84.1470(10)° γ=82.961(2)°
(<i>E</i>)-2-Oxo-<i>N</i>'-(3,4,5-trimethoxybenzylidene)-2<i>H</i>-chromene-3-carbohydrazide dimethyl sulfoxide hemisolvate
C20H18N2O6,0.5C2H6OS
Acta Crystallographica Section E (2019) 75, 10 1403-1410
a=33.0258(7)Å b=5.44120(10)Å c=22.4342(4)Å
α=90° β=107.203(2)° γ=90°
Bis(mefloquinium) butanedioate ethanol monosolvate
2(C17H17F6N2O),C4H4O42,C2H6O
Acta Crystallographica Section E (2019) 75, 8 1162-1168
a=10.0405(2)Å b=14.6482(4)Å c=14.6547(4)Å
α=100.7450(10)° β=93.830(2)° γ=98.497(2)°
6-Isopropyl-3-(2-nitro-1-phenylethyl)-1<i>H</i>-indole
C19H20N2O2
Acta Crystallographica Section E (2016) 72, 5 699-703
a=12.4525(9)Å b=5.7360(4)Å c=12.5896(9)Å
α=90° β=116.081(6)° γ=90°
2-(4-Methoxyphenyl)-3-(2-nitro-1-phenylethyl)-1<i>H</i>-indole
C23H20N2O3
Acta Crystallographica Section E (2016) 72, 5 699-703
a=9.2014(5)Å b=9.4543(7)Å c=21.6201(14)Å
α=98.563(4)° β=93.416(4)° γ=98.354(4)°
<i>N</i>'-[(1<i>E</i>)-(5-Nitrofuran-2-yl)methylidene]thiophene-2-carbohydrazide
C10H7N3O4S
Acta Crystallographica Section E (2016) 72, 7 1025-1031
a=17.4072(16)Å b=17.4072(16)Å c=14.4881(10)Å
α=90° β=90° γ=90°
Ethyl 5-chloro-1<i>H</i>-indole-2-carboxylate
C11H10ClNO2
Acta Crystallographica Section E (2016) 72, 7 964-968
a=13.7168(6)Å b=4.57830(10)Å c=16.5929(11)Å
α=90° β=97.464(7)° γ=90°
Ethyl 5-chloro-3-iodo-1<i>H</i>-indole-2-carboxylate
C11H9ClINO2
Acta Crystallographica Section E (2016) 72, 7 964-968
a=7.7733(5)Å b=7.8240(5)Å c=10.4594(7)Å
α=86.085(8)° β=80.575(7)° γ=71.308(6)°
2-{[2,8-Bis(trifluoromethyl)quinolin-4-yl](hydroxy)methyl}piperidin-1-ium (+)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate
C17H17F6N2O,C10H8F3O3
Acta Crystallographica Section E (2016) 72, 6 872-877
a=7.52100(10)Å b=13.3056(3)Å c=14.8445(4)Å
α=69.2830(10)° β=76.336(2)° γ=85.759(2)°
2-Bromo-1,4-dihydronaphthalene-1,4-dione--1,8-dihydroxy-9,10-dihydroanthracene-9,10-dione (1/1)
C10H5BrO2,C14H8O4
Acta Crystallographica Section E (2017) 73, 5 738-745
a=17.55090(12)Å b=4.85939(3)Å c=22.83423(16)Å
α=90.0° β=106.7429(7)° γ=90.0°
(<i>E</i>)-1-Methyl-5-nitro-1<i>H</i>-imidazole-2-carbaldehyde <i>O</i>-benzyloxime
C12H12N4O3
Acta Crystallographica Section E (2018) 74, 3 380-384
a=7.6399(5)Å b=10.5071(7)Å c=14.9243(11)Å
α=90° β=97.942(3)° γ=90°
(<i>E</i>)-1-Methyl-5-nitro-1<i>H</i>-imidazole-2-carbaldehyde <i>O</i>-(4-fluorobenzyl) oxime
C12H11FN4O3
Acta Crystallographica Section E (2018) 74, 3 380-384
a=7.5484(2)Å b=12.6442(4)Å c=13.4150(9)Å
α=90° β=102.988(7)° γ=90°
(<i>E</i>)-1-Methyl-5-nitro-1<i>H</i>-imidazole-2-carbaldehyde <i>O</i>-(4-bromobenzyl) oxime
C12H11BrN4O3
Acta Crystallographica Section E (2018) 74, 3 380-384
a=7.6024(2)Å b=12.7526(3)Å c=13.8954(5)Å
α=90° β=104.869(2)° γ=90°
(<i>E</i>)-<i>N</i>'-(2-Chlorophenylmethylidene)-<i>N</i>-methyl-2-(thiophen-2-yl)acetohydrazide
C14H13ClN2OS
Acta Crystallographica Section E (2018) 74, 3 313-318
a=9.1918(7)Å b=20.3575(14)Å c=7.2721(5)Å
α=90° β=96.360(2)° γ=90°